Roche · 2 hours ago
2026 Summer Intern - Cell and Gene Therapy Manufacturing
Roche is a leading biotechnology company, and they are seeking a Summer Intern for their Cell and Gene Therapy Manufacturing team. The intern will gain hands-on experience in GMP manufacturing processes, working on cutting-edge cell therapies and supporting various manufacturing and validation activities.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Gain experience in cutting edge cell therapies
Receive hands-on training from the HIT Manufacturing team
Support HIT Manufacturing with process efficiency and optimization
Familiarize yourself with the different departments within the pharmaceutical industry
Qualification
Required
Must be pursuing a Bachelor's Degree (enrolled student)
Required Majors: Biochemistry, Molecular/ Cellular Biology, Bioengineering, Chemical Engineering, Biotechnology
General computing skills and Gsuite
Experience with technical writing or protocol generation
Data analysis
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Cell culture or aseptic technique experience preferred
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Recent News
2026-01-23
2026-01-22
Company data provided by crunchbase